Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

[Does 24,25 dihydroxycholecalciferol have a physiological and pathophysiological role?].

J L Sebert, A Fournier, G Lambrey

|January 1, 1982

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Nonadrenergic and noncholinergic arterial dilatation and venoconstriction are mediated by calcitonin gene-related peptide1 and neurokinin-1 receptors, respectively, in the mesenteric vasculature of the rat after perivascular nerve stimulation.

The Journal of pharmacology and experimental therapeutics·1992

Same author

Studies of 300-microns microcapsules: I. Use of arginine esterase release by microencapsulated prostatic cells as a measure of membrane permeability.

Transplantation proceedings·1992

Same author

Neuropeptide Y potentiates selectively the N-methyl-D-aspartate response in the rat CA3 dorsal hippocampus. I. Involvement of an atypical neuropeptide Y receptor.

The Journal of pharmacology and experimental therapeutics·1992

Same author

Neuropeptide Y potentiates the N-methyl-D-aspartate response in the CA3 dorsal hippocampus. II. Involvement of a subtype of sigma receptor.

The Journal of pharmacology and experimental therapeutics·1992

Same author

Neuropeptide Y inhibits alpha-MSH release from rat hypothalamic slices through a pertussis toxin-sensitive G protein.

Brain research·1992

Same author

Ketodiet, physiological calcium intake and native vitamin D improve renal osteodystrophy.

Kidney international·1992

24,25-dihydroxyvitamin D3 (24,25(OH)2D3) plays a vital role in bone health, distinct from the primary vitamin D metabolite. This metabolite is crucial for normal bone formation and mineralization, and may help prevent excessive bone resorption.

Area of Science:

Endocrinology
Metabolism
Bone Biology

Background:

Vitamin D metabolites, including 1,25(OH)2D3 and 24,25(OH)2D3, are critical for calcium and phosphorus homeostasis.
While 1,25(OH)2D3 is well-established for its effects on calcium absorption and bone resorption, the role of 24,25(OH)2D3 has been less understood.

Purpose of the Study:

To review current experimental and human data on the physiological and pathophysiological roles of 24,25(OH)2D3.
To compare the effects of 24,25(OH)2D3 and 1,25(OH)2D3 on various biological processes.

Main Methods:

Literature review of experimental and human studies.
In vitro experiments investigating the effects of vitamin D metabolites on cellular processes.

Main Results:

Related Experiment Videos

24,25(OH)2D3 is less potent than 1,25(OH)2D3 in stimulating intestinal calcium absorption and bone resorption.
In vitro studies suggest 24,25(OH)2D3 stimulates proteoglycan synthesis and inhibits parathyroid hormone (PTH)-induced bone resorption, effects not observed with 1,25(OH)2D3.
24,25(OH)2D3 appears essential for normal bone formation and mineralization and may counteract excessive bone resorption.

Conclusions:

Despite lower potency in classical vitamin D actions, 24,25(OH)2D3 has unique physiological roles.
This metabolite is vital for maintaining bone health, particularly bone formation, mineralization, and potentially regulating bone resorption.
Further research is warranted to fully elucidate the distinct functions of 24,25(OH)2D3 in human health and disease.